MUFG Americas Holdings Corp lessened its position in Stryker Corporation (NYSE:SYK) by 11.8% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 18,939 shares of the medical technology company’s stock after selling 2,542 shares during the quarter. MUFG Americas Holdings Corp’s holdings in Stryker were worth $2,933,000 as of its most recent filing with the SEC.
Other institutional investors have also recently made changes to their positions in the company. WFG Advisors LP increased its position in shares of Stryker by 1.6% during the 2nd quarter. WFG Advisors LP now owns 2,041 shares of the medical technology company’s stock worth $283,000 after purchasing an additional 32 shares during the last quarter. Advisory Services Network LLC increased its position in shares of Stryker by 1.8% during the 2nd quarter. Advisory Services Network LLC now owns 3,398 shares of the medical technology company’s stock worth $472,000 after purchasing an additional 59 shares during the last quarter. Linscomb & Williams Inc. increased its position in shares of Stryker by 1.2% during the 2nd quarter. Linscomb & Williams Inc. now owns 10,486 shares of the medical technology company’s stock worth $1,455,000 after purchasing an additional 121 shares during the last quarter. Cornerstone Capital Management Holdings LLC. increased its position in shares of Stryker by 0.3% during the 2nd quarter. Cornerstone Capital Management Holdings LLC. now owns 53,572 shares of the medical technology company’s stock worth $7,434,000 after purchasing an additional 135 shares during the last quarter. Finally, Scotia Capital Inc. increased its position in shares of Stryker by 4.5% during the 2nd quarter. Scotia Capital Inc. now owns 5,590 shares of the medical technology company’s stock worth $776,000 after purchasing an additional 243 shares during the last quarter. 74.71% of the stock is currently owned by institutional investors and hedge funds.
SYK has been the topic of several recent analyst reports. Robert W. Baird raised Stryker from a “neutral” rating to an “outperform” rating and boosted their price target for the stock from $161.00 to $173.00 in a research report on Thursday, November 16th. Needham & Company LLC reaffirmed a “hold” rating on shares of Stryker in a research report on Friday, November 3rd. JPMorgan Chase & Co. raised Stryker from a “neutral” rating to an “overweight” rating in a research report on Tuesday, January 2nd. ValuEngine raised Stryker from a “hold” rating to a “buy” rating in a research report on Tuesday, November 14th. Finally, Piper Jaffray Companies reaffirmed a “buy” rating and set a $156.00 price target on shares of Stryker in a research report on Friday, October 27th. Two equities research analysts have rated the stock with a sell rating, nine have given a hold rating and fourteen have given a buy rating to the stock. The stock has an average rating of “Hold” and a consensus target price of $162.50.
In related news, VP William E. Berry, Jr. sold 1,306 shares of the business’s stock in a transaction on Thursday, February 1st. The stock was sold at an average price of $164.42, for a total value of $214,732.52. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Lonny J. Carpenter sold 5,000 shares of the business’s stock in a transaction on Friday, February 2nd. The shares were sold at an average price of $163.76, for a total value of $818,800.00. Following the completion of the sale, the insider now owns 94,253 shares of the company’s stock, valued at $15,434,871.28. The disclosure for this sale can be found here. Insiders sold a total of 16,840 shares of company stock valued at $2,749,989 over the last 90 days. 7.40% of the stock is currently owned by corporate insiders.
Stryker Corporation (NYSE SYK) opened at $159.87 on Friday. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.59 and a current ratio of 2.29. Stryker Corporation has a one year low of $124.89 and a one year high of $170.00. The company has a market capitalization of $59,395.74, a P/E ratio of 24.43, a PEG ratio of 2.28 and a beta of 0.70.
Stryker (NYSE:SYK) last released its quarterly earnings results on Tuesday, January 30th. The medical technology company reported $1.96 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.95 by $0.01. The business had revenue of $3.47 billion during the quarter, compared to the consensus estimate of $3.42 billion. Stryker had a return on equity of 24.56% and a net margin of 8.20%. The firm’s quarterly revenue was up 9.9% on a year-over-year basis. During the same period in the previous year, the company posted $1.78 EPS. research analysts anticipate that Stryker Corporation will post 7.12 earnings per share for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Monday, April 30th. Investors of record on Thursday, March 29th will be paid a $0.47 dividend. The ex-dividend date is Wednesday, March 28th. This represents a $1.88 annualized dividend and a yield of 1.18%. Stryker’s dividend payout ratio (DPR) is presently 70.15%.
COPYRIGHT VIOLATION NOTICE: “MUFG Americas Holdings Corp Sells 2,542 Shares of Stryker Corporation (SYK)” was first posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this story on another domain, it was illegally stolen and reposted in violation of United States & international copyright & trademark legislation. The original version of this story can be read at https://www.dispatchtribunal.com/2018/02/17/mufg-americas-holdings-corp-sells-2542-shares-of-stryker-corporation-syk.html.
Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.
Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.